Biotricity, Inc.
BTCY
$0.48
-$0.02-4.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.51% | 18.12% | 14.31% | 14.09% | 13.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.51% | 18.12% | 14.31% | 14.09% | 13.55% |
| Cost of Revenue | -9.42% | -8.64% | -12.98% | -15.00% | -21.21% |
| Gross Profit | 29.99% | 28.57% | 26.43% | 29.40% | 35.17% |
| SG&A Expenses | -21.32% | -28.65% | -25.70% | -14.59% | -18.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.35% | -21.94% | -22.27% | -14.19% | -19.81% |
| Operating Income | 91.85% | 86.23% | 72.26% | 49.79% | 51.24% |
| Income Before Tax | 63.03% | 62.45% | 40.25% | 26.85% | 24.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 63.03% | 62.45% | 40.25% | 26.85% | 24.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.03% | 62.45% | 40.25% | 26.85% | 24.83% |
| EBIT | 91.85% | 86.23% | 72.26% | 49.79% | 51.24% |
| EBITDA | 91.94% | 86.30% | 72.31% | 49.83% | 51.27% |
| EPS Basic | 86.22% | 86.57% | 58.09% | 37.97% | 29.97% |
| Normalized Basic EPS | 83.42% | 84.46% | 72.74% | 52.53% | 43.63% |
| EPS Diluted | 86.20% | 86.56% | 58.08% | 37.97% | 29.97% |
| Normalized Diluted EPS | 83.42% | 84.46% | 72.74% | 52.53% | 43.63% |
| Average Basic Shares Outstanding | 88.15% | 140.10% | 142.58% | 99.48% | 57.51% |
| Average Diluted Shares Outstanding | 88.15% | 140.10% | 142.58% | 99.48% | 57.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.70% | -1.66% | -1.80% | -0.37% | 0.87% |